AbbVie announces $5 billion increase to stock repurchase program
The board of directors of AbbVie has authorized a $5 billion increase to AbbVie's existing stock repurchase program. Purchases may be made from time to time at management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions. December 13, 2018